Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Barr Laboratory BRL -- Ignore unavailable to you. Want to Upgrade?

To: harkenman who wrote (139)	11/6/1998 4:15:00 PM
From: James Silverman	Read Replies (1) \| Respond to of 207

<<Any news on the latest movement? Both DRMD and BRL are having unusual price/volume movements. Any info? Conjugated Estrogen, Prozac, Tamoxifen? Please advise>> Earnings looked good. The stock market has been on a roll. The stock was depressed. Preven received a great amount of attention. Prozac trial is set for January. Tamox was approved for new indications. Doubt there's any connection between DRMD/BRL given DRMD is a shadow both in quality and reputation as compared to BRL. So imo the rebound is just the culmination of a number of factors, all positive, mainly relating to increasing funds flowing into the stock market and drug companies in general.